Zimmer Biomet Holdings ZBH · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
108.33
+2.59%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Zimmer Biomet Holdings
From its filings with the US Securities and Exchange Commission
Zimmer Biomet Holdings is based in Warsaw, Indiana and is incorporated in Delaware. Its shares trade on NYSE under the ticker ZBH. It is a member of the S&P 500. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $8.23bn and net income of $705.1m. At that date it held total assets of $23.09bn and shareholders' equity of $12.70bn. By business, Knees. brought in 40.4% of revenue, followed by SET. at 26.1% and Hips. at 25.4%. By region, United States [Member] accounted for 57.9%, followed by Non-US [Member] at 42.1%.
Zimmer Biomet Holdings was incorporated in Delaware in 2001. Our history dates to 1927, when Zimmer Manufacturing Company, a predecessor, was founded in Warsaw, Indiana. On August 6, 2001, we were spun off from our former parent and became an independent public company. In 2015, we acquired LVB Acquisition, Inc. (“LVB”), the parent company of Biomet, Inc. (“Biomet”), and LVB and Biomet became our wholly-owned subsidiaries. In connection with the merger, we changed our name from Zimmer Holdings, Inc. to Zimmer Biomet Holdings, Inc.
Our primary customers include orthopedic surgeons, neurosurgeons, and other specialists, healthcare institutions, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent clinicians.
We market and sell products through two principal channels: 1) direct to healthcare institutions, such as hospitals and ambulatory surgery centers, referred to as direct channel accounts; and 2) through stocking distributors and healthcare dealers. With direct channel accounts and some healthcare dealers, inventory is generally consigned to sales agents or customers. With sales to stocking distributors, some healthcare dealers and some hospitals, and at times to some direct channel accounts, title to product typically passes upon shipment. Consignment sales represented approximately 85 percent of our net sales in 2025. No individual customer accounted for more than 2 percent of our net sales for 2025.
Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 25 Jul 2001
- Employees
- 17,000
- Website
- zimmerbiomet.com ↗
- Head office
- 345 EAST MAIN STREET, WARSAW, IN, 46580
- Incorporated in
- DE
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Ivan TornosChairman of the Board, President, Chief Executive Officer, since 2018$15.0m
- Mr. Suketu UpadhyayChief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain$5.9m
- Mr. Kevin ThornalGroup President - Global Businesses, Americas
- Mr. Wilfred Van ZuilenPresident - Europe, Middle East and Africa$3.5m
- Mr. Sang YiGroup President, Asia Pacific$3.2m
- Ms. Lori WinklerChief Human Resources Officer, Senior Vice President
- Mr. Chad PhippsSenior Vice President, General Counsel, Secretary$2.9m
- Ms. Kristen CardilloSenior Vice President, Chief Communications Officer
- Mr. Jehanzeb NoorSenior Vice President, Chief Strategy, Innovation and Business Development Officer
- Mr. Paul StellatoChief Accounting Officer, Vice President, Controller
- Mr. Michael FarrellLead Independent Director$348,371
- Ms. Betsy BernardIndependent Director$348,347
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 62
- Environment
- 42
- Social
- 84
- Governance
- 61
- Direct emissions (scope 1)
- 10,191 t
- Energy emissions (scope 2)
- 109,243 t
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Zimmer Biomet Holdings Inc, a global leader in the orthopedic medical device industry, possesses several key strengths:
Weaknesses
- Despite its strengths, Zimmer Biomet also faces certain weaknesses:
Opportunities
- Zimmer Biomet can explore several opportunities to further grow its business:
Threats
- Zimmer Biomet should be cautious of the following potential threats:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.